360 One Quant Fund
The scheme seeks to generate long term capital appreciation for investors from a portfolio of equity and equity related securities selected based on quant theme.
Growthvine rating: 5/5 — ranked #11 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹17.77 (as of 2026-10-01) |
|---|
| AUM | ₹873 Cr |
|---|
| Expense ratio | 1.79% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Pranav Mise |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| Sharpe ratio | 0.62 |
|---|
| Standard deviation | 17.84% |
|---|
| Max drawdown | −22.83% |
|---|
| Alpha | 3.45 |
|---|
| Beta | 1.11 |
|---|
Over 5 years, captured 75.6% of NIFTY Alpha 50's upside and 61.6% of its downside.
Market cap allocation
| Large cap | 71.8% |
|---|
| Mid cap | 28.1% |
|---|
| Small cap | 0.0% |
|---|
Concentration
| Top 5 holdings | 18.0% |
|---|
| Top 10 holdings | 34.6% |
|---|
| Total holdings | 36 |
|---|
Top holdings
- Divis Laboratories Ltd. — 4.1%
- TVS Motor Company Ltd. — 3.5%
- Aurobindo Pharma Ltd. — 3.5%
- Torrent Pharmaceuticals Ltd. — 3.4%
- Bajaj Auto Limited — 3.4%
- Cholamandalam Investment and Finance Company Ltd — 3.4%
- APL Apollo Tubes Limited — 3.3%
- Polycab India Limited — 3.3%
- Titan Company Limited — 3.3%
- Bajaj Finance Limited — 3.2%
Top sectors
- Finance & Investments — 15.7%
- Automobile — 13.2%
- Pharma & Biotech — 12.5%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −10.4% | Q4 (Bottom) | #147 of 167 |
| 2025 | 8.4% | Q1 (Top) | #31 of 132 |
| 2024 | 21.7% | Q2 | #33 of 86 |
| 2023 | 44.8% | Q1 (Top) | #9 of 66 |
| 2022 | 3.0% | Q2 | #28 of 55 |